Shares of Ibotta, Inc. (NYSE:IBTA - Get Free Report) have received a consensus recommendation of "Reduce" from the nine research firms that are currently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and one has issued a buy recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $33.1429.
IBTA has been the topic of a number of recent research reports. Weiss Ratings reissued a "sell (d)" rating on shares of Ibotta in a research report on Friday, March 27th. Wall Street Zen downgraded Ibotta from a "hold" rating to a "sell" rating in a research report on Saturday, February 28th. Finally, Wells Fargo & Company lifted their target price on Ibotta from $30.00 to $34.00 and gave the stock an "equal weight" rating in a research report on Thursday, February 26th.
View Our Latest Stock Report on Ibotta
Ibotta Stock Performance
Shares of NYSE:IBTA opened at $35.28 on Monday. Ibotta has a 52-week low of $19.10 and a 52-week high of $62.74. The company has a market cap of $732.77 million, a P/E ratio of 320.76 and a beta of -0.61. The stock's 50-day moving average is $29.06 and its 200-day moving average is $26.14.
Ibotta (NYSE:IBTA - Get Free Report) last released its earnings results on Wednesday, February 25th. The company reported $0.29 earnings per share for the quarter, topping analysts' consensus estimates of ($0.01) by $0.30. Ibotta had a return on equity of 1.04% and a net margin of 1.04%.The business had revenue of $88.53 million for the quarter. During the same period last year, the business earned $0.67 earnings per share. The firm's quarterly revenue was down 10.0% compared to the same quarter last year. As a group, equities analysts predict that Ibotta will post -0.42 EPS for the current year.
Ibotta announced that its board has authorized a share repurchase program on Wednesday, March 11th that permits the company to buyback $100.00 million in outstanding shares. This buyback authorization permits the company to repurchase up to 21.2% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's leadership believes its shares are undervalued.
Insider Buying and Selling
In other Ibotta news, insider Marisa Daspit sold 2,956 shares of the firm's stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $24.06, for a total transaction of $71,121.36. Following the completion of the transaction, the insider owned 127,597 shares in the company, valued at $3,069,983.82. This trade represents a 2.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 20.92% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in IBTA. Deutsche Bank AG lifted its stake in Ibotta by 3,449.8% during the fourth quarter. Deutsche Bank AG now owns 369,890 shares of the company's stock worth $8,408,000 after purchasing an additional 359,470 shares during the period. Citigroup Inc. lifted its stake in Ibotta by 90.2% during the third quarter. Citigroup Inc. now owns 641,337 shares of the company's stock worth $17,861,000 after purchasing an additional 304,183 shares during the period. ARK Investment Management LLC lifted its stake in Ibotta by 39.3% during the third quarter. ARK Investment Management LLC now owns 907,386 shares of the company's stock worth $25,271,000 after purchasing an additional 255,899 shares during the period. Vanguard Group Inc. lifted its stake in Ibotta by 17.3% during the third quarter. Vanguard Group Inc. now owns 1,570,896 shares of the company's stock worth $43,749,000 after purchasing an additional 232,027 shares during the period. Finally, Marshall Wace LLP bought a new position in Ibotta during the second quarter worth about $8,397,000.
About Ibotta
(
Get Free Report)
Ibotta NYSE: IBTA is a Denver‐based mobile commerce platform that connects consumers, retailers and brands through a unified cash-back rewards experience. Users access the Ibotta mobile app or browser extension to unlock rebates on everyday purchases, redeemable on groceries, retail goods, travel bookings and digital services. The platform integrates with major supermarket chains, big‐box retailers and online merchants, enabling shoppers to earn automatic cash-back both in physical stores and across e-commerce channels.
Founded in 2012 by co‐founder and CEO Bryan Leach, Ibotta has evolved from a simple rebate app into a comprehensive performance marketing partner for consumer goods companies.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ibotta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ibotta wasn't on the list.
While Ibotta currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.
These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.